Metabolic syndrome and colorectal cancer: The protective role of mediterranean diet-a case-control study

Angiology

Volumn 63, Issue 5, 2012, Pages 390-396

  Kontou, Niki ^a,b   Psaltopoulou, Theodora ^c   Soupos, Nick ^c   Polychronopoulos, Evangelos ^a   Xinopoulos, Dimitrios ^b   Linos, Athena ^c   Panagiotakos, Demosthenes B ^a  

^a HAROKOPIO UNIVERSITY   (Greece)

^b SAINT SAVVAS HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

alcohol; colorectal cancer; Mediterranean diet; metabolic syndrome; olive oil

Indexed keywords

ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; DIETARY INTAKE; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDITERRANEAN DIET; METABOLIC SYNDROME X; PATIENT COMPLIANCE; SCORING SYSTEM; SMOKING;

EID: 84861901708     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319711421164     Document Type: Article

References (35)

1. Siddiqui AA.. Metabolic syndrome and its association with colorectal cancer: a review. Am J Med Sci. 2011 ; 341 (3). 227-231
2. Mikhailidis DP, Lioudaki E, Vrentzos GE, et al Angiology. 2011 :
3. Daskalopoulou SS, Mikhailidis DP, Elisaf M.. Prevention and treatment of the metabolic syndrome. Angiology. 2004 ; 55 (6). 589-612
4. World Health Organization. http://globocan.iarc.fr/factsheets/ populations/factsheet.asp?Assessed July 20, 2010.
5. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective Report. Washington DC: AICR ; 2007 :
6. Williams MT, Hord NG.. The role of dietary factors in cancer prevention: beyond fruits and vegetables. Nutr Clin Pract. 2005 ; 20 (4). 451-459
7. Smith SC.. Multiple risk factors for cardiovascular disease and diabetes mellitus. Am J Med. 2007 ; 120 (3 suppl 1). 3-11
8. Chimonas T, Athyros VG, Ganotakis E, et al. Assessing the Treatment Effect in Metabolic Syndrome Without Perceptible Diabetes (ATTEMPT) Collaborative Group. Cardiovascular risk factors and estimated 10-year risk of fatal cardiovascular events using various equations in Greeks with metabolic syndrome. Angiology. 2010 ; 61 (1). 49-57
9. Giovannucci E.. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr. 2007 ; 86 (3). s836 - s842
10. Ashbeck EL, Jacobs ET, Martinez ME, Gerner EW, Lance P, Thompson PA.. Components of metabolic syndrome and metachronous colorectal neoplasia. Cancer Epidemiol Biomarkers Prev. 2009 ; 18 (4). 1134-1143
11. Kaneko R, Sato Y, An Y, et al. Clinico-epidemiologic study of the metabolic syndrome and lifestyle factors associated with the risk of colon adenoma and adenocarcinoma. Asian Pacific J Cancer Prev. 2010 ; 11 (4). 975-983
12. Stürmer T, Buring JE, Lee IM, Gaziano JM, Glynn RJ.. Metabolic abnormalities and risk for colorectal cancer in the Physicians Health study. Cancer Epidemiol Biomarkers Prev. 2006 ; 15 (12). 2391-2397
13. Ahmed RH, Schmitz KH, Anderson KE, Rosamond WD, Folsom AR.. The metabolic syndrome and risk of incident colorectal cancer. Cancer. 2006 ; 107 (1). 28-36
14. Kim JH, Lim YJ, Sung IK, et al. Is metabolic syndrome a risk factor for colorectal adenoma?. Cancer Epidemiol Biomarkers Prev. 2007 ; 16 (8). 1543-1546
15. Chan AOO, Jim MH, Lam KF, et al. Prevalence of colorectal neoplasm among patients with newly diagnosed coronary artery disease. JAMA. 2007 ; 298 (12). 1412-1419
16. Bowers K, Albanes D, Limburg P, et al. A prospective study of Anthropometric and clinical measurements associated with insulin resistance syndrome and colorectal cancer in male smokers. Am J Epidemiol. 2006 ; 164 (7). 652-664
17. Morita T, Tabata S, Mineshita M, Mizoue T, Moore MA, Kono S.. The metabolic syndrome is associated with increased risk of colorectal adenoma development: the self-defence forces health study. Asian Pacific J Cancer Prev. 2005 ; 6 (4). 485-489
18. Tsilidis KK, Brancati FL, Pollak MN, et al. Metabolic syndrome components and colorectal adenoma in the CLUE II cohort. Cancer Causes Control. 2010 ; 21 (1). 1-10
19. Panagiotakos DB.. α-Priori vs. α-posterior methods in dietary pattern analysis: a review in nutrition epidemiology. Nutr Bull. 2008 ; 33 (4). 311-315
20. Bountziouka V, Bathrellou E, Giotopoulou A, et al Nutr Metab Cardiovasc Dis. 2011 :
21. Panagiotakos DB, Pitsavos C, Arvaniti F, et al. Adherence to the Mediterranean food pattern predicts the prevalence of hypertension, hypercholesterolemia, diabetes and obesity, among healthy adults: the accuracy of the MedDietScore. Prev Med. 2007 ; 44 (4). 335-340
22. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001 ; 285 (19). 2486-2497
23. Ferrari P, Jenab M, Norat T, et al. Lifetime and baseline alcohol intake and risk of colon and rectal cancers in the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer. 2007 ; 121 (9). 2065-2072
24. Alkerwi A, Boutsen M, Vaillant M, et al. Alcohol consumption and the prevalence of metabolic syndrome: a meta-analysis of observational studies. Atherosclerosis. 2009 ; 204 (2). 624-635
25. Lee KW, Park BJ, Kang HT, Lee YJ.. Alcohol-drinking patterns and metabolic syndrome risk: the 2007 Korean national health and nutrition examination survey. Alcohol. 2011 ; 45 (5). 499-505
26. Pelucchi C, Negri E, Talamini R, et al. Metabolic syndrome is associated with colorectal cancer in men. Eur J Cancer Prev. 2010 ; 46 (10). 1866-1872
27. Colangelo LA, Gapstur SM, Gann PH, Dyer AR, Liu K.. Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev. 2002 ; 11 (4). 385-391
28. Franceschi S, Dal Maso L, Augustin L, et al. Dietary glycemic load and colorectal cancer risk. Ann Oncol. 2001 ; 12 (2). 173-178
29. Esfahani A, Wong JMW, Mirrahimi A, Srichaikul K, Jenkins DJ, Kendall CW.. The glycemic index: physiological significance. J Am Coll Nutr. 2009 ; 28 (suppl). 439s - 445s
30. Hoda MR, Keely SJ, Bertelsen LS, Junger WG, Dharmasena D, Barrett KE.. Leptin acts as a mitogenic and antiapoptotic factor for colonic cancer cells. Br J Surg. 2007 ; 94 (3). 346-354
31. Arts IC, Hollman PC.. Polyphenols and disease risk in epidemiological studies. Am J Clin Nutr. 2005 ; 81 (suppl 1). 317s - 325s
32. Kastorini CM, Milionis HJ, Esposito K, Giugliano D, Goudevenos JA, Panagiotakos DB.. The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals. J Am Coll Cardiol. 2011 ; 57 (11). 1299-1313
33. Pelucchi C, Bosetti C, Negri E, Lipworth L, La Vecchia C.. Olive oil and cancer risk: an update of epidemiological findings through 2010. Curr Pharm Des. 2011 ; 17 (8). 805-812
34. Corona G, Spencer JPE, Dessì MA.. Extra virgin olive oil phenolics: absorption, metabolism, and biological activities in the GI tract. Toxicol Ind Health. 2009 ; 25 (4-5). 285-293
35. Paniagua JA, Gallego de la Sacristana A, Sánchez E, et al. A MUFA-rich diet improves postprandial glucose, lipid and GLP-1 responses in insulin-resistant subjects. J Am Coll Nutr. 2007 ; 26 (5). 434-444